The detection of heart markers

Disease of heart head blood-vessel is a serious threat to human health life of the disease, at present the disease of heart head blood-vessel mortality rate is the world first, by detecting heart markers, can effectively prevent and accurate diagnosis and effective treatment in time to correct some serious disease of heart head blood-vessel. The heart of the test is actually through markers supporting medical equipment for some typical material inside the heart of the testing, such as N-the brain, the titanium precursor, myocardial ctni, etc.

Perlong medical equipment company is specialized in the research and development, production, sales in vitro diagnostic reagents and medical equipment is a joint venture enterprise. The company strictly carries out the "scientific and technological innovation, quality first" policy, the overall to implement iso13485:2003 and YY0287 quality management and standards, the main products of various medical equipment including heart and infectious diseases diagnosis products such as fast.

Such as N-the brain, the titanium precursor, myocardial ctni, creatine kinase isozyme, muscle red protein, a myocardial infarction, the d-dimer kits, etc, the products adopt quantitative detection method fast, convenient and fast.

In October 2007 the European heart association, the American heart association, the American heart association and the world heart federation composition working group released "myocardial infarction" global uniform definition standard recommend the best use of myocardial for troponin diagnosis myocardial infarction. The 2008 European heart failure in recent years according to the guidelines continue to post evidence-based medical results will type B, the titanium and N-end brain natriuretic titanium precursor as the first choice of heart failure diagnosis index, established it in cardiac function in the inspection of the position, in the public didn't learn to heart disease published NI-ProBNP country expert consensus, will the world-ProBNP clinical know NI promotion to a new level, the development of heart markers field, for the overwhelming majority of cardiovascular disease in the early diagnosis and treatment to win the precious time, promote the patient's recovery progress.

NI-ProBNP (N-end brain natriuretic peptide precursor) half-life is 120 minutes, only for 20 minutes BNP half-life NI-ProBNP in the bloodstream BNP is 5-10 times so NT-ProBNP more than BNP suitable for in vitro testing, for the specimen no special treatment.

Article : From Perlong medical (http://www.pl999.net/)
Attention:If you want to copy, please attach the website.